Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption

Matthew McKenzie, Danae Liolitsa, Natalya Akinshina, Michelangelo Campanella, Sanjay Sisodiya, Ian Hargreaves, Niranjanan Nirmalananthan, Mary G. Sweeney, Patrick M. Abou-Sleiman, Nicholas W. Wood, Michael G. Hanna, Michael R. Duchen

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Mitochondrial encephalomyopathy and lactic acidosis with strokelike episodes (MELAS) is a severe young onset stroke disorder without effective treatment. We have identified a MELAS patient harboring a 13528A→G mitochondrial DNA (mtDNA) mutation in the Complex I ND5 gene. This mutation was homoplasmic in mtDNA from patient muscle and nearly homoplasmic (99.9%) in blood. Fibroblasts from the patient exhibited decreased mitochondrial membrane potential (Δψm) and increased lactate production, consistent with impaired mitochondrial function. Transfer of patient mtDNA to a new nuclear background using transmitochondrial cybrid fusions confirmed the pathogenicity of the 13528A→G mutation; Complex I-linked respiration and Δψm were both significantly reduced in patient mtDNA cybrids compared with controls. Inhibition of the adenine nucleotide translocase or the F1F0-ATPase with bongkrekic acid or oligomycin caused a loss of potential in patient mtDNA cybrid mitochondria, indicating a requirement for glycolytically generated ATP to maintain Δψ m. This was confirmed by inhibition of glycolysis with 2-deoxy-D-glucose, which caused depletion of ATP and mitochondrial depolarization in patient mtDNA cybrids. These data suggest that in response to impaired respiration due to the mtDNA mutation, mitochondria consume ATP to maintain Δψm, representing a potential pathophysiological mechanism in human mitochondrial disease.

Original languageEnglish
Pages (from-to)36845-36852
Number of pages8
JournalJournal of Biological Chemistry
Volume282
Issue number51
DOIs
Publication statusPublished - Dec 21 2007

Fingerprint

Mitochondrial Encephalomyopathies
Mitochondrial Genes
Mitochondrial DNA
Genes
Adenosine Triphosphate
Lactic Acidosis
Mutation
Mitochondria
Respiration
Bongkrekic Acid
ATP Translocases Mitochondrial ADP
Oligomycins
Patient Transfer
Mitochondrial Diseases
Mitochondrial Membrane Potential
Deoxyglucose
Depolarization
Glycolysis
Fibroblasts
Virulence

ASJC Scopus subject areas

  • Biochemistry

Cite this

McKenzie, M., Liolitsa, D., Akinshina, N., Campanella, M., Sisodiya, S., Hargreaves, I., ... Duchen, M. R. (2007). Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption. Journal of Biological Chemistry, 282(51), 36845-36852. https://doi.org/10.1074/jbc.M704158200

Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption. / McKenzie, Matthew; Liolitsa, Danae; Akinshina, Natalya; Campanella, Michelangelo; Sisodiya, Sanjay; Hargreaves, Ian; Nirmalananthan, Niranjanan; Sweeney, Mary G.; Abou-Sleiman, Patrick M.; Wood, Nicholas W.; Hanna, Michael G.; Duchen, Michael R.

In: Journal of Biological Chemistry, Vol. 282, No. 51, 21.12.2007, p. 36845-36852.

Research output: Contribution to journalArticle

McKenzie, M, Liolitsa, D, Akinshina, N, Campanella, M, Sisodiya, S, Hargreaves, I, Nirmalananthan, N, Sweeney, MG, Abou-Sleiman, PM, Wood, NW, Hanna, MG & Duchen, MR 2007, 'Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption', Journal of Biological Chemistry, vol. 282, no. 51, pp. 36845-36852. https://doi.org/10.1074/jbc.M704158200
McKenzie, Matthew ; Liolitsa, Danae ; Akinshina, Natalya ; Campanella, Michelangelo ; Sisodiya, Sanjay ; Hargreaves, Ian ; Nirmalananthan, Niranjanan ; Sweeney, Mary G. ; Abou-Sleiman, Patrick M. ; Wood, Nicholas W. ; Hanna, Michael G. ; Duchen, Michael R. / Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 51. pp. 36845-36852.
@article{fc69913bead34f4aaec021d0d07f84ce,
title = "Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption",
abstract = "Mitochondrial encephalomyopathy and lactic acidosis with strokelike episodes (MELAS) is a severe young onset stroke disorder without effective treatment. We have identified a MELAS patient harboring a 13528A→G mitochondrial DNA (mtDNA) mutation in the Complex I ND5 gene. This mutation was homoplasmic in mtDNA from patient muscle and nearly homoplasmic (99.9{\%}) in blood. Fibroblasts from the patient exhibited decreased mitochondrial membrane potential (Δψm) and increased lactate production, consistent with impaired mitochondrial function. Transfer of patient mtDNA to a new nuclear background using transmitochondrial cybrid fusions confirmed the pathogenicity of the 13528A→G mutation; Complex I-linked respiration and Δψm were both significantly reduced in patient mtDNA cybrids compared with controls. Inhibition of the adenine nucleotide translocase or the F1F0-ATPase with bongkrekic acid or oligomycin caused a loss of potential in patient mtDNA cybrid mitochondria, indicating a requirement for glycolytically generated ATP to maintain Δψ m. This was confirmed by inhibition of glycolysis with 2-deoxy-D-glucose, which caused depletion of ATP and mitochondrial depolarization in patient mtDNA cybrids. These data suggest that in response to impaired respiration due to the mtDNA mutation, mitochondria consume ATP to maintain Δψm, representing a potential pathophysiological mechanism in human mitochondrial disease.",
author = "Matthew McKenzie and Danae Liolitsa and Natalya Akinshina and Michelangelo Campanella and Sanjay Sisodiya and Ian Hargreaves and Niranjanan Nirmalananthan and Sweeney, {Mary G.} and Abou-Sleiman, {Patrick M.} and Wood, {Nicholas W.} and Hanna, {Michael G.} and Duchen, {Michael R.}",
year = "2007",
month = "12",
day = "21",
doi = "10.1074/jbc.M704158200",
language = "English",
volume = "282",
pages = "36845--36852",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption

AU - McKenzie, Matthew

AU - Liolitsa, Danae

AU - Akinshina, Natalya

AU - Campanella, Michelangelo

AU - Sisodiya, Sanjay

AU - Hargreaves, Ian

AU - Nirmalananthan, Niranjanan

AU - Sweeney, Mary G.

AU - Abou-Sleiman, Patrick M.

AU - Wood, Nicholas W.

AU - Hanna, Michael G.

AU - Duchen, Michael R.

PY - 2007/12/21

Y1 - 2007/12/21

N2 - Mitochondrial encephalomyopathy and lactic acidosis with strokelike episodes (MELAS) is a severe young onset stroke disorder without effective treatment. We have identified a MELAS patient harboring a 13528A→G mitochondrial DNA (mtDNA) mutation in the Complex I ND5 gene. This mutation was homoplasmic in mtDNA from patient muscle and nearly homoplasmic (99.9%) in blood. Fibroblasts from the patient exhibited decreased mitochondrial membrane potential (Δψm) and increased lactate production, consistent with impaired mitochondrial function. Transfer of patient mtDNA to a new nuclear background using transmitochondrial cybrid fusions confirmed the pathogenicity of the 13528A→G mutation; Complex I-linked respiration and Δψm were both significantly reduced in patient mtDNA cybrids compared with controls. Inhibition of the adenine nucleotide translocase or the F1F0-ATPase with bongkrekic acid or oligomycin caused a loss of potential in patient mtDNA cybrid mitochondria, indicating a requirement for glycolytically generated ATP to maintain Δψ m. This was confirmed by inhibition of glycolysis with 2-deoxy-D-glucose, which caused depletion of ATP and mitochondrial depolarization in patient mtDNA cybrids. These data suggest that in response to impaired respiration due to the mtDNA mutation, mitochondria consume ATP to maintain Δψm, representing a potential pathophysiological mechanism in human mitochondrial disease.

AB - Mitochondrial encephalomyopathy and lactic acidosis with strokelike episodes (MELAS) is a severe young onset stroke disorder without effective treatment. We have identified a MELAS patient harboring a 13528A→G mitochondrial DNA (mtDNA) mutation in the Complex I ND5 gene. This mutation was homoplasmic in mtDNA from patient muscle and nearly homoplasmic (99.9%) in blood. Fibroblasts from the patient exhibited decreased mitochondrial membrane potential (Δψm) and increased lactate production, consistent with impaired mitochondrial function. Transfer of patient mtDNA to a new nuclear background using transmitochondrial cybrid fusions confirmed the pathogenicity of the 13528A→G mutation; Complex I-linked respiration and Δψm were both significantly reduced in patient mtDNA cybrids compared with controls. Inhibition of the adenine nucleotide translocase or the F1F0-ATPase with bongkrekic acid or oligomycin caused a loss of potential in patient mtDNA cybrid mitochondria, indicating a requirement for glycolytically generated ATP to maintain Δψ m. This was confirmed by inhibition of glycolysis with 2-deoxy-D-glucose, which caused depletion of ATP and mitochondrial depolarization in patient mtDNA cybrids. These data suggest that in response to impaired respiration due to the mtDNA mutation, mitochondria consume ATP to maintain Δψm, representing a potential pathophysiological mechanism in human mitochondrial disease.

UR - http://www.scopus.com/inward/record.url?scp=37549067007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549067007&partnerID=8YFLogxK

U2 - 10.1074/jbc.M704158200

DO - 10.1074/jbc.M704158200

M3 - Article

C2 - 17940288

AN - SCOPUS:37549067007

VL - 282

SP - 36845

EP - 36852

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -